E
Emergent Biosolutions D
D
EBS
7.15000
USD
-0.32
(-4.22%)
مغلق
حجم التداول
25,860
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
388,086,463
الأخبار المقالات
العنوان: Emergent Biosolutions
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consistingof Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segmentwhich consists of NARCAN and other commercial products.